Propranolol as therapy for cerebral cavernous malformations: a cautionary note is a research paper published in Journal of Translational Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institute of Neurological Disorders and Stroke
Grant: P01 NS09252
National Institutes of Health
Grant: F30 HL140871
NINDS NIH HHS
Grant: P01 NS092521
National Institutes of Health
Grant: 5P01NS092521-03
Signaling Aberrations and Cerebral Cavernous Malformation Pathogenesis
National Institutes of Health
Grant: 5F30HL140871-02
Investigating the Molecular Pathways of Cerebral Cavernous Malformation Maturation
Be Brave for Life
FWCI
1.18
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals